142 related articles for article (PubMed ID: 38218896)
1. Prostein expression in human tumors: a tissue microarray study on 19,202 tumors from 152 different Tumor entities.
Viehweger F; Böcker C; Weidemann S; Freytag M; Menz A; Büscheck F; Luebke AM; Putri D; Kluth M; Hube-Magg C; Hinsch A; Lennartz M; Lutz F; Reiswich V; Höflmayer D; Fraune C; Möller K; Bernreuther C; Lebok P; Sauter G; Steurer S; Dum D; Marx AH; Simon R; Krech T; Clauditz TS; Jacobsen F; Gorbokon N; Burandt E; Minner S; Kind S
Diagn Pathol; 2024 Jan; 19(1):12. PubMed ID: 38218896
[TBL] [Abstract][Full Text] [Related]
2. The role of P501S and PSA in the diagnosis of metastatic adenocarcinoma of the prostate.
Sheridan T; Herawi M; Epstein JI; Illei PB
Am J Surg Pathol; 2007 Sep; 31(9):1351-5. PubMed ID: 17721190
[TBL] [Abstract][Full Text] [Related]
3. Immunohistochemical expression of prostatic antigens in adenocarcinoma and villous adenoma of the urinary bladder.
Lane Z; Hansel DE; Epstein JI
Am J Surg Pathol; 2008 Sep; 32(9):1322-6. PubMed ID: 18670358
[TBL] [Abstract][Full Text] [Related]
4. Diagnostic utility of immunohistochemical marker prostein for evaluation of primary and metastatic prostatic carcinomas.
Garudadri G; Rao BV; Sundaram C; Fonseca D; Murthy SS; Sharma R; Rao TS
Indian J Pathol Microbiol; 2020 Feb; 63(Supplement):S18-S24. PubMed ID: 32108621
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic Utility of Prostein, Uroplakin II and SATB2 for Diagnosing Carcinoma of Unknown Primary Origin: A Systematic Immunohistochemical Profiling.
Mochizuki K; Kawai M; Odate T; Tahara I; Inoue T; Kasai K; Nakazawa T; Katoh R; Kondo T
Anticancer Res; 2018 Aug; 38(8):4759-4766. PubMed ID: 30061246
[TBL] [Abstract][Full Text] [Related]
6. Prostein expression is highly restricted to normal and malignant prostate tissues.
Kalos M; Askaa J; Hylander BL; Repasky EA; Cai F; Vedvick T; Reed SG; Wright GL; Fanger GR
Prostate; 2004 Aug; 60(3):246-56. PubMed ID: 15176054
[TBL] [Abstract][Full Text] [Related]
7. Immunohistochemical differentiation of high-grade prostate carcinoma from urothelial carcinoma.
Chuang AY; DeMarzo AM; Veltri RW; Sharma RB; Bieberich CJ; Epstein JI
Am J Surg Pathol; 2007 Aug; 31(8):1246-55. PubMed ID: 17667550
[TBL] [Abstract][Full Text] [Related]
8. Diagnostic utility of p501s (prostein) in comparison to prostate specific antigen (PSA) for the detection of metastatic prostatic adenocarcinoma.
Yin M; Dhir R; Parwani AV
Diagn Pathol; 2007 Oct; 2():41. PubMed ID: 17963516
[TBL] [Abstract][Full Text] [Related]
9. Identification and characterization of prostein, a novel prostate-specific protein.
Xu J; Kalos M; Stolk JA; Zasloff EJ; Zhang X; Houghton RL; Filho AM; Nolasco M; Badaró R; Reed SG
Cancer Res; 2001 Feb; 61(4):1563-8. PubMed ID: 11245466
[TBL] [Abstract][Full Text] [Related]
10. NKX3.1 as a marker of prostatic origin in metastatic tumors.
Gurel B; Ali TZ; Montgomery EA; Begum S; Hicks J; Goggins M; Eberhart CG; Clark DP; Bieberich CJ; Epstein JI; De Marzo AM
Am J Surg Pathol; 2010 Aug; 34(8):1097-105. PubMed ID: 20588175
[TBL] [Abstract][Full Text] [Related]
11. FABP1 expression in human tumors: a tissue microarray study on 17,071 tumors.
Dum D; Ocokoljic A; Lennartz M; Hube-Magg C; Reiswich V; Höflmayer D; Jacobsen F; Bernreuther C; Lebok P; Sauter G; Luebke AM; Burandt E; Marx AH; Simon R; Clauditz TS; Minner S; Menz A; Büscheck F; Gorbokon N; Steurer S; Blessin NC; Krech T
Virchows Arch; 2022 Dec; 481(6):945-961. PubMed ID: 35951102
[TBL] [Abstract][Full Text] [Related]
12. Prostate adenocarcinomas aberrantly expressing p63 are molecularly distinct from usual-type prostatic adenocarcinomas.
Tan HL; Haffner MC; Esopi DM; Vaghasia AM; Giannico GA; Ross HM; Ghosh S; Hicks JL; Zheng Q; Sangoi AR; Yegnasubramanian S; Osunkoya AO; De Marzo AM; Epstein JI; Lotan TL
Mod Pathol; 2015 Mar; 28(3):446-56. PubMed ID: 25216229
[TBL] [Abstract][Full Text] [Related]
13. Diagnostic and prognostic role of pancreatic secretory granule membrane major glycoprotein 2 (GP2) immunohistochemistry: A TMA study on 27,681 tumors.
Uhlig R; Günther K; Bröker N; Gorbokon N; Lennartz M; Dwertmann Rico S; Reiswich V; Viehweger F; Büscheck F; Kluth M; Hube-Magg C; Hinsch A; Fraune C; Bernreuther C; Lebok P; Sauter G; Izbicki JR; Steurer S; Burandt E; Marx AH; Krech T; Simon R; Minner S; Clauditz TS; Jacobsen F
Pathol Res Pract; 2022 Oct; 238():154123. PubMed ID: 36137400
[TBL] [Abstract][Full Text] [Related]
14. Sensitivity of HOXB13 as a Diagnostic Immunohistochemical Marker of Prostatic Origin in Prostate Cancer Metastases: Comparison to PSA, Prostein, Androgen Receptor, ERG, NKX3.1, PSAP, and PSMA.
Kristiansen I; Stephan C; Jung K; Dietel M; Rieger A; Tolkach Y; Kristiansen G
Int J Mol Sci; 2017 May; 18(6):. PubMed ID: 28555048
[TBL] [Abstract][Full Text] [Related]
15. NKX3.1 and Prostein Expression in Testicular Tissue and Sex Cord-stromal Tumors.
Arnesen C; Eich ML; Pena MDCR; Cappel JR; Schwartz L; Rais-Bahrami S; Faraj SF; Prieto Granada C; Gordetsky JB
Am J Surg Pathol; 2020 Jan; 44(1):61-67. PubMed ID: 31498176
[TBL] [Abstract][Full Text] [Related]
16. Comparison of different prostatic markers in lymph node and distant metastases of prostate cancer.
Queisser A; Hagedorn SA; Braun M; Vogel W; Duensing S; Perner S
Mod Pathol; 2015 Jan; 28(1):138-45. PubMed ID: 24925052
[TBL] [Abstract][Full Text] [Related]
17. Diagnostic utility of p63/P501S double sequential immunohistochemical staining in differentiating urothelial carcinoma from prostate carcinoma.
Srinivasan M; Parwani AV
Diagn Pathol; 2011 Jul; 6():67. PubMed ID: 21777423
[TBL] [Abstract][Full Text] [Related]
18. Immunohistochemistry of ductal adenocarcinoma of the prostate and adenocarcinomas of non-prostatic origin: a comparative study.
Seipel AH; Samaratunga H; Delahunt B; Wiklund P; Clements M; Egevad L
APMIS; 2016 Apr; 124(4):263-70. PubMed ID: 26778368
[TBL] [Abstract][Full Text] [Related]
19. Diagnostic and prognostic impact of cytokeratin 18 expression in human tumors: a tissue microarray study on 11,952 tumors.
Menz A; Weitbrecht T; Gorbokon N; Büscheck F; Luebke AM; Kluth M; Hube-Magg C; Hinsch A; Höflmayer D; Weidemann S; Fraune C; Möller K; Bernreuther C; Lebok P; Clauditz T; Sauter G; Uhlig R; Wilczak W; Steurer S; Minner S; Burandt E; Krech R; Dum D; Krech T; Marx A; Simon R
Mol Med; 2021 Feb; 27(1):16. PubMed ID: 33588765
[TBL] [Abstract][Full Text] [Related]
20. Cadherin-17 (CDH17) expression in human cancer: A tissue microarray study on 18,131 tumors.
Jacobsen F; Pushpadevan R; Viehweger F; Freytag M; Schlichter R; Gorbokon N; Büscheck F; Luebke AM; Putri D; Kluth M; Hube-Magg C; Hinsch A; Höflmayer D; Fraune C; Bernreuther C; Lebok P; Sauter G; Minner S; Steurer S; Simon R; Burandt E; Dum D; Lutz F; Marx AH; Krech T; Clauditz TS
Pathol Res Pract; 2024 Apr; 256():155175. PubMed ID: 38452580
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
